Cargando…
Modulation of Fibrosis in Systemic Sclerosis by Nitric Oxide and Antioxidants
Systemic sclerosis (scleroderma: SSc) is a multisystem, connective tissue disease of unknown aetiology characterized by vascular dysfunction, autoimmunity, and enhanced fibroblast activity resulting in fibrosis of the skin, heart, and lungs, and ultimately internal organ failure, and death. One of t...
Autores principales: | Dooley, Audrey, Bruckdorfer, K. Richard, Abraham, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206384/ https://www.ncbi.nlm.nih.gov/pubmed/22111028 http://dx.doi.org/10.1155/2012/521958 |
Ejemplares similares
-
Reduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud's phenomenon
por: Kundu, Devi, et al.
Publicado: (2014) -
Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase
por: Iwakiri, Yasuko
Publicado: (2015) -
Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease
por: Kozij, Natalie K., et al.
Publicado: (2017) -
Enhancement of Nitric Oxide Bioavailability by Modulation of Cutaneous Nitric Oxide Stores
por: Suschek, Christoph V., et al.
Publicado: (2022) -
Oxidative Damage and Antioxidative Therapy in Systemic Sclerosis
por: Grygiel-Górniak, Bogna, et al.
Publicado: (2014)